Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 9/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7610158 | 0.82 | SLC6A2 (1.00) | SLC6A2 | |
| SCHEMBL9673016 | 0.80 | SLC6A2 (0.46) | SLC6A2 | |
| SCHEMBL8441967 | 0.80 | SLC6A2 (0.73) | SLC6A2 | |
| SCHEMBL7615812 | 0.78 | SLC6A2 (1.00) | SLC6A2 | |
| SCHEMBL7611251 | 0.77 | SLC6A2 (0.62) | SLC6A2 | |
| Fumaric Acid SCHEMBL7612128 | 0.76 | SLC6A2 (0.79) | SLC6A2 | |
| Maleic Acid SCHEMBL7612124 | 0.76 | SLC6A2 (0.79) | SLC6A2 | |
| SCHEMBL8539582 | 0.75 | SLC6A2 (0.57) | SLC6A2 | |
| SCHEMBL8541743 | 0.75 | SLC6A2 (0.56) | SLC6A2 | |
| Hydrochloric Acid SCHEMBL8544931 | 0.74 | SLC6A2 (0.56) | SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0468401-B1 | 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process for their preparation and their use as medicaments | HOECHST MARION ROUSSEL INC (US) | 1998-09-16 | — | — | EP | disclosed |
| US-5102891-A | Useful for treating various memory dysfunctions such as alzheimer's disease | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1992-04-07 | — | — | US | disclosed |
| EP-0468401-A2 | 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1992-01-29 | — | — | EP | disclosed |